Latest Trading Suspensions News

Antilles Gold Limited has had its trading suspension lifted on the ASX following the release of its quarterly activity and cash flow reports for June 2025, reopening the stock to market activity.

Envirosuite shareholders have decisively approved the proposed acquisition by Ideagen EVS BidCo Pty Limited, moving the deal closer to completion pending final court approval.

Forrestania Resources Limited has had its trading suspension lifted following the announcement of a proposed acquisition, signaling a pivotal moment for the mining explorer.

The ASX has suspended the securities of Antilles Gold, Heramed, and Syntara due to missed periodic report deadlines, signaling compliance concerns ahead of potential reinstatement.

Conico Ltd has resolved a key legal dispute and secured $1.4 million in convertible loans, setting the stage for a rights offer and share consolidation as it plans to resume trading.

XTC Lithium Limited is progressing its Carachi Lithium Project in Argentina through strategic partnership discussions and environmental assessments, while completing the sale of its Southern Cross assets in Western Australia.

Winchester Energy Limited has resumed trading on the ASX following confirmation that it now meets director requirements under the Corporations Act. This development ends a trading suspension tied to governance compliance.

Forrestania Resources has voluntarily suspended trading on the ASX as it prepares to announce a significant acquisition, signaling a potentially transformative move for the mining company.

Tigers Realm Coal’s planned sale of its Russian subsidiaries faces significant delays and a pricing impasse, with regulatory hurdles and sanctions complicating the exit process and triggering an ASX trading suspension.

FinTech Chain Limited has requested suspension of its shares from ASX trading to enable its removal from the official list, marking a significant shift for the fintech company.

International Graphite Limited (ASX – IG6) has had its trading suspension lifted following the announcement of a new agreement to develop a graphite processing facility in Europe.

Advanced Health Intelligence Ltd (AHI) reports robust commercial progress and strategic funding moves in Q1 2025 despite ongoing ASX trading suspension and recent NASDAQ delisting. Key partnerships and technology validations position the company for a strong global scale-up.